ARTICLE | Company News
Maxygen, Siga deal
November 6, 2000 8:00 AM UTC
The companies will develop vaccines using MAXY’s antigens and SIGA’s vaccine delivery technology that uses commensal bacteria as antigen presenters to stimulate mucosal immunity. ...